Texas Monthly; Getty
Marveling at the size of the elephants or squealing at the cuteness of the meerkats, visitors come regularly to the Houston Zoo for the chance to observe exotic animals up-close. Meanwhile, just a few blocks away, a laboratory houses a markedly different sort of zoo. Instead of furry and feathered creatures in enclosures, there are thousands of blood samples in a pair of freezers surrounded by dozens of white boards covered by mathematical equations.
This is the DNA Zoo, where a team of thirty-plus scientists use cutting-edge genomic technology in service of boosting the survival chances for countless endangered species work that could contribute to human health as well. The lab has acquired genetic samples of 4,234 animals representing 1,105 species, largely obtained from zoos and parks including the Houston Zoo, San Antonio Zoo, Sea World, and the Texas State Aquarium. In 2019, they opened a counterpart lab in Australia to focus on species unique to that cont
(Photo courtesy of Getty Images)
The goal of this Phase II study is to determine the safest and most effective number of doses of stem cells to slow the progression of Parkinson s disease symptoms so patients can continue to enjoy their active lives.
Newswise A Phase II clinical trial to assess mesenchymal adult stem cells as a disease-modifying therapy for Parkinson s disease has been launched at The University of Texas Health Science Center at Houston (UTHealth). Studies have shown mesenchymal stem cells can migrate to the sites of injury and respond to the environment by secreting several anti-inflammatory and growth factor molecules that can restore tissue equilibrium and disrupt neuronal death, said Mya C. Schiess, MD, professor in the Department of Neurology and director and founder of the movement disorder subspeciality clinic and fellowship program at McGovern Medical School at UTHealth. The stem cells interact directly with the immune cells, leading to an anti-in
National Primary Care Leader MDVIP Expands Texas Footprint to Over 110 Physicians in the State Mousumi Chanda-Kim, M.D., and Steven Spencer, M.D., F.A.A.F.P., Open MDVIP-Affiliated Practices in Austin and Houston Areas
News provided by
Share this article
Share this article
BOCA RATON, Fla., April 15, 2021 /PRNewswire/ MDVIP, the market leader in personalized healthcare with a network of over 1,100 doctors, today announced the addition of two new affiliated practices to its growing primary care footprint both in the southwest and nationally. Board-certified internist Mousumi Chanda-Kim, M.D., in Austin, and board-certified family medicine physician Steven Spencer, M.D., F.A.A.F.P., in Katy, have joined MDVIP to deliver a better healthcare experience with an emphasis on wellness and prevention. The new practices further expand MDVIP s footprint to over 110 affiliated physicians in Texas.
Biomerica, Inc (BMRA) reported consolidated sales of $3 62 million for the fiscal third quarter streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.